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Obesity-induces Organ and 
Tissue Specific Tight Junction 
Restructuring and Barrier 
Deregulation by Claudin Switching
Rizwan Ahmad1, Bilal Rah1, Dhundy Bastola2, Punita Dhawan1,3 & Amar B. Singh1,3
Obesity increases susceptibility to multiple organ disorders, however, underlying mechanisms remain 
unclear. The subclinical inflammation assisted by obesity-induced gut permeability may underlie 
obesity-associated co-morbidities. Despite eminent clinical significance of the obesity led gut barrier 
abnormalities, its precise molecular regulation remains unclear. It is also unknown whether barrier 
deregulations, similar to the gut, characterize other vital organs in obese individuals. The claudin 
family of proteins is integral to the tight junction (TJ), the apical cell-cell adhesion and a key regulator 
of the epithelial barrier. Using comprehensive physiological and biochemical analysis of intestinal 
and renal tissues from high-fat diet fed mice, critical for maintaining metabolic homeostasis, this 
study demonstrates that profound TJ-restructuring by organ and tissue-specific claudin switching 
characterize obese organs. Protein expression and cellular distribution were examined. In-silico analysis 
further highlighted potential association of select claudins, modulated by the obesity, with signaling 
and metabolic pathways of pathological significance. In vitro studies using Leptin or DCA-treatment 
suggested causal significance of obesity-induced changes in tissue microenvironment in regulating 
barrier deregulations in tissue-specific manner. Overall, current findings advances our understanding of 
the molecular undertakings of obesity associated changes that help predispose to specific diseases and 
also identifies novel windows of preventive and/or therapeutic interventions.
Obesity is a serious metabolic disorder that predisposes individuals to and/or increases susceptibility to multiple 
pathological conditions including gastrointestinal disorders and cancers, diabetes and renal pathologies1. At cur-
rent, 36.5% adults in the U.S.A. are obese and the annual medical cost of managing obesity was estimated to be a 
whopping $147 billion as far back as in 20082–4. However, once considered a problem only in high-income coun-
tries, overweight and obesity is now dramatically on the rise in low- and middle-income countries, particularly in 
urban settings5. To prevent this social and economic catastrophe, we need immediate measures that also require 
improved molecular understanding of the problem. In this regard, a common trait identified in obese individuals 
and associated diseases is the prevalence of leaky/hyper-permeable gut6. Additionally, the heightened antigen/
immune interaction due to leaky gut can impose local or systemic inflammatory burden in obese individuals to 
increase susceptibility to specific diseases. However, despite its apparent clinical significance, molecular under-
taking of increased mucosal leakiness in obese individuals remain poorly understood. It is also not clear whether 
obesity associated barrier deregulation is limited to the gut epithelium or it is systemic. Importantly, barrier 
deregulation is central to undesired antigen-immune interaction and inflammation.
Tight junction (TJ), the principal determinant of epithelial paracellular permeability, helps to regulate epi-
thelial barrier properties7. While it is organized by specific interactions between a wide spectrum of structural, 
adapter and signaling proteins, the integral role of claudin family of transmembrane proteins in regulating tight 
junction’s structure/function is now well-established8. Importantly, not all claudin proteins are alike and they 
differ drastically in their ability to regulate trans-epithelial resistance, a measure of an epithelial monolayer integ-
rity and/or paracellular ion transport9. For instance, claudin-1 expression in epithelial cells increases TER while 
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claudin-2 expression decreases TER and increases paracellular permeability for ions and non-charged small mol-
ecules10. In accordance, in mammalian body, claudin-2 is expressed only among leaky epithelia including the 
intestinal crypts and proximal tubular epithelium, and is specifically absent from tighter epithelia like collecting 
duct and urinary bladder11, 12. Moreover, studies from our as well as other laboratories have demonstrated that 
permeability enhancing disease conditions markedly increase claudin-2 expression13–15. However, detailed anal-
ysis of the modulation of claudin proteins in gut epithelia and other organs in correlation with obesity induced 
gut hyper-permeability is lacking.
In the current study, we have performed comprehensive physiological and biochemical in vitro and in vivo 
analyses to demonstrate that obesity induced by the intake of high fat diet induces gut hyper-permeability by 
tissue-specific claudin switching in obese gut epithelium compared to lean subjects. We further demonstrate 
that obesity induced claudin switching and tight junction restructuring is organ specific and may depend on 
macro-environmental changes. We anticipate the outcome to improve molecular understanding of obesity asso-
ciated disorders, and help improve clinical management of the problem.
Results
High fat diet induces obese phenotype and glucose intolerance. Mice included in the study were 
similar in age (8–10 weeks old; N = 8), body weight, and male/female ratio, between the study groups. As per 
expectation, body weight gain in HFD-fed mice was appreciably higher after as little as 2 weeks of feeding (ver-
sus ND-mice; p < 0.05; Fig. 1(a)), which became significantly higher 6 weeks post-feeding of HFD diet (versus 
ND-mice; p < 0.001) (Fig. 1(a)). Remarkably, when sacrificed at 20 weeks post-HFD feeding, obese mice also 
demonstrated significant increases in liver (p < 0.01), heart (p < 0.001) and kidney (p < 0.01) weight compared to 
the ND-fed mice (Fig. 1(d)). The oral glucose tolerance test (OGTT), the benchmark assay to determine insulin 
intolerance, conducted at week 20 post-HFD feeding, before sacrificing the mice, further demonstrated failure 
of the blood glucose clearance from blood (Fig. 1(b), p < 0.001)) in HFD-fed mice, suggesting chronic glucose 
intolerance. Taken together, these data confirmed validity of the high-fat diet feeding in inducing obesity and 
associated metabolic impediments.
HFD-diet induces hyper-permeable gut and mucosal inflammation. We further examined if mice 
fed on high fat diet possessed leakier gut than ND-fed mice. The ND- and HFD-mice (after 18 weeks of feed-
ing differential diet) were subjected to intestinal permeability assay, as described in “Materials and Methods”13. 
A significant increase (p < 0.001) in FITC-dextran levels, administered orally, in blood plasma in HFD-mice 
compared to ND-mice confirmed presence of leaky gut in HFD-mice (Fig. 1(h)). By using the Ussing chamber 
system mounted with freshly isolated mucosal epithelium, we further confirmed this finding which demonstrated 
a significant decrease in the TER in HFD-mice (p < 0.05) while conductance across the epithelium increased 
(p < 0.05) compared to the ND-mice (Fig. 1(f and g)). A leaky gut promotes mucosal inflammation16. Moreover, 
obesity induced inflammatory reprogramming is believed to promote susceptibility of obese individuals to 
metabolic disorders17–19. Therefore, we examined inflammatory signatures in HFD-fed mice gut versus ND-fed 
mice. Histological evaluation of the H&E slides of swiss-rolled intestine and colon indeed demonstrated areas 
of immune infiltration and epithelial damage in HFD-mice compared to the ND-mice (Fig. 1(e)). Significant 
decreases in the colon (p < 0.01) and small intestine (p < 0.001) lengths in obese mice (versus lean mice) fur-
ther supported mucosal inflammation in HFD-mice compared to the ND-mice (Fig. 1(c). Taken together, our 
data demonstrated that high-fat diet induced obesity causes gut hyper-permeability and subclinical mucosal 
inflammation.
Obesity induces claudin switching for tight junction restructuring in intestinal epithe-
lium. Mucosal barrier is a complex structure consisting of multiple epithelial and immune components. 
However, key role of the tight junction in this barrier regulation is widely recognized13, 20–22. Therefore, we per-
formed a comprehensive analysis of tight junction integral proteins (TJPs). Concurrent analysis of adherent junc-
tion proteins (AJPs), E-cadherin and β-catenin, between HFD- and ND-mice helped determine specificity of 
the outcome. Glut-2 expression in HFD-mice versus ND-mice served as positive control which, as predicted, 
was significantly increased in HFD-mice intestine (versus ND mice, p < 0.001) (Fig. 2(a)). Immunoblot anal-
ysis demonstrated significant however diverse changes in claudin expression in HFD-mice versus ND-mice. In 
specific, expression of claudin-1 (p < 0.05), claudin-3 (p < 0.05), claudin-4 (p < 0.05), claudin-7 (p < 0.001) and 
claudin-15 (p < 0.01) decreased significantly in HFD-mice compared to the ND-mice (Fig. 2(b and d)). In con-
trast, expression of claudin-2, the leaky claudin protein, was significantly upregulated (p < 0.05) (Fig. 2(b and d)). 
In same samples, expression of occludin, yet another TJP or beta-catenin, an AJP, remained largely unaltered yet 
E-cadherin expression decreased significantly (verses ND-mice, p < 0.01) (Fig. 2(b, c and d)).
However, barrier function can be altered due to the changes in cellular content of barrier-associated proteins 
and/or their cellular distribution3, 13, 23, 24. Therefore, we further examined if expected membrane tethered cel-
lular localization of proteins under investigation is also altered in obese mice intestine. Regrettably, immunos-
taining results for occludin and claudin-15 did not provide satisfactory outcome and were not pursued further. 
E-cadherin and β-catenin demonstrated expected lateral membrane localization in ND-mice intestine, which 
remained largely unaltered in HFD-mice intestine (Fig. 2(e)). Furthermore, in ND-mice claudin-1, -3 and -7 
were expressed in luminal and apicolateral membrane localization (Fig. 2(e)). In HFD-mice, immunostaining for 
all three proteins was drastically downregulated however the loss in lateral membrane locations appeared robust 
than the luminal expressed protein. In contrast, claudin-2 immunoreactivity was minimal and predominantly 
luminal in the ND-mice, which increased sharply in HFD-mice and it was present in the luminal position and the 
cell cytoplasm (Fig. 2(e)). Taken together, our data suggested that obesity-induced gut leakiness associates with 
sweeping modulation of the barrier composition in small intestine epithelium.
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Obesity induced claudin switching is specific for the large intestine. We further determined 
whether obesity induces similar changes in cell-cell adhesions in small and large intestine. Potential changes in 
above described proteins were determined in colonic epithelium. Immunoblot analysis using total colon lysate 
Figure 1. High fat diet induces obesity and associated metabolic and physiological changes in C57/BL6 mice. 
8–10 weeks old mice were subjected to normal chow or high fat diet for 20 weeks (N = 8). (a) body weight changes 
in mice over the period of ND- or HFD-diet feeding; (b) Oral glucose tolerance test (OGTT); (c) Changes in 
colonic and intestinal length in HFD-versus ND-fed mice; (d) Changes in organ weight in HFD-versus ND-fed 
mice; (e) Representative images showing immune cell infiltration in mice colon with HFD- versus ND-mice. (f 
and g) Colonic trans-epithelial resistance and conductance across the mucosal sheet changes during HFD-mice 
versus control; (h) Intestinal permeability (for FITC-dextran) in HFD versus ND-mice. Values are presented as 
mean ± SEM ***P ≤ 0.001, **P ≤ 0.01 and *P ≤ 0.05 compared to control mice on ND.
www.nature.com/scientificreports/
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demonstrated significant upregulation of Glut-2 expression in HFD-mice (p < 0.05) compared to the ND-mice, as 
in small intestine (Fig. 3(a)). The changes in cell-cell adhesion proteins were also robust however differed sharply 
compared to the small intestine, suggesting tissue specificity. A significant decrease in claudin-1 (p < 0.05), 
Figure 2. High fat diet induces restructuring of tight junction (but not adherent junction) to modulate mucosal 
barrier function in small intestine: Immunoblot analysis of total tissue lysate prepared using small intestine from 
mice fed on normal chow or high fat diet for 20 weeks (N = 4). (a) Glut-2 expression in HFD and ND-fed mice, 
as positive control; (b) Immunoblot analysis to determine changes in TJPs antigen-specific antibodies; (c) 
Immunoblot analysis to determine potential changes in AJPs (E-Cadherin and β-Catenin) in obese versus lean 
mice; (d) Quantitative analysis of immunoblot band intensity for respective protein; (e) Representative confocal 
immunofluorescent images of TJ and AJPs of small intestine from HFD- and ND-fed mice. Values are presented 
as mean ± SEM *P ≤ 0.05 compared to control (normal chow fed mice; ND) mice.
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 5125  | DOI:10.1038/s41598-017-04989-8
claudin-3 (p < 0.05) and claudin-15 (p < 0.01) expressions in HFD-mice colon compared to the ND-mice was 
found (Fig. 3(b and d)). Claudin-4 and occludin expressions remained largely unaltered in these samples (Fig. 3(b 
and d)). However, contrasting the significant decrease in small intestine in HFD-mice, colonic claudin-7 expres-
sion was significantly upregulated in HFD-mice (versus ND-mice, p < 0.05). The pore forming claudin, claudin-2, 
was however significantly upregulated (versus ND-Mice, p < 0.01) in HFD-mice colon as in small intestine 
(Fig. 3(b and d)). Interestingly, the changes among AJPs in the colon were similar to the small intestine where 
Figure 3. High fat diet induces colon specific restructuring of tight junction and adherent junction: 
Immunoblot analysis of total tissue lysate prepared using the Colon from ND- and HFD-fed mice (N = 4). (a) 
Glut-2 expression in HFD and ND-fed mice, as positive control; (b) Immunoblot analysis to determine changes 
in TJPs using antigen-specific antibodies; (c) Immunoblot analysis to determine changes in AJPs including 
E-cadherin and β-catenin; (d) Densitometry analysis of the immunoblot band intensity for respective protein; 
(e) Representative immunofluorescent images of TJ and AJPs of colon from HFD- and ND-fed mice. Values are 
presented as mean ± SEM **P ≤ 0.01; *P ≤ 0.05 compared to control (normal chow fed mice; ND) mice.
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E-cadherin levels in HFD-mice decreased significantly (p < 0.05) though cellular β-catenin content remained 
largely unaltered (Fig. 3(c and d)). Immunofluorescence microscopy revealed minimal claudin-2 expression at 
the base of the colonic crypt while claudin-3 expression was concentrated predominantly among differentiated 
colonocytes at the crypt top in ND-mice colon (Fig. 3(e)), as previously described15. The marked upregulation of 
claudin-2 expression in obese mice colon was also distributed to a higher crypt depth, and was expressed as both, 
membrane-tethered and cytosolic protein. In contrast, claudin-3 immunoreactivity in HFD-mice was simply 
suppressed (versus ND-mice). Both, claudin-1 and claudin-7 were present on the lateral membrane throughout 
the crypt however differed drastically in their intensity, with claudin-7 being the prominent protein Fig. 3(e)). 
In obese mice colon, despite an increase in intensity, claudin-7 expression remained localized predominantly 
at the lateral membrane. In contrast, the decrease in claudin-1 expression appeared more pronounced at lat-
eral membrane locations compared to the luminal protein. Also, the lateral membrane localized E-cadherin and 
beta-catenin expressions in ND-mice colon appeared partially deregulated in HFD-mice colon. Taken together, 
our data demonstrated that obesity led restructuring of mucosal barrier is tissue specific and differs between the 
small and the large intestine epithelium.
Obesity induced tight junction remodeling and claudin switching is organ specific. Obesity 
associated changes in the plasma glucose and triglyceride concentrations prime to hypertension and renal pathol-
ogies is evidenced by increased albuminuria, alterations in kidney morphology, and renal lipid accumulation25. 
Considering the newly defined role of claudin proteins in regulating paracellular ion homeostasis and the findings 
that genetic modification of claudin proteins lead to deregulated renal salt handling and functional impairment26, 
we also determined obesity-induced changes in claudin composition in the renal epithelium of HFD-mice ver-
sus ND-mice. As described, the kidney weight in HFD-mice increased significantly (versus ND-mice, p < 0.01) 
(Fig. 1(d)). Histopathological analysis of H&E slides further demonstrated signs of renal injury in HFD-mice 
(Fig. 4(e)). Immunoblot analysis using total kidney lysate further demonstrated robust changes in claudin pro-
teins and tight junction composition in the renal epithelium, which however contrasted the changes in gut epi-
thelium. No major changes were found specifically in claudin-1 expression in HFD-mice kidney versus ND-mice 
kidney (Fig. (b and d)). Similarly, claudin-15, a paracellular Na+ channel, expression and/or cellular distribution 
remained largely unaltered. However, expression of claudin-2 protein, also a paracellular Na+ channel expressed 
predominantly in the proximal tubular epithelium, decreased significantly in HFD-mice (versus ND-mice, 
p < 0.05) (Fig. 4(b and d)). Similar significant decreases in claudin-3 (p < 0.05) and claudin-7 (p < 0.05) expres-
sions characterized renal epithelium in obese mice. In same samples, claudin-4 expression was markedly upreg-
ulated (versus ND mice, p < 0.01) (Fig. 4(b and d)). HFD-induced obesity did not affect occludin, E-cadherin or 
beta-catenin expressions to significant levels (Fig. 4(b and d)). Immuno-fluorescent analysis of candidate claudin 
proteins supported the outcome from immunoblot analysis (Fig. 4(f)). Taken together, our data demonstrated 
organ and tissue specificity for obesity-induced changes in claudin expression and tight junction restructuring.
Deoxycholic acid (DCA) and leptin induce claudin switching to modulate barrier composition 
and apico-basal permeability in intestinal epithelial cells. Dietary fat affects bile acid metabolism, 
excess fat processing and absorption requires increased amount of bile acids in the digestive tract. Accordingly, 
high-fat diet elevates bile acids concentration in the intestinal lumen. Remarkably, studies have further demon-
strated direct association between orally delivered deoxycholic acid (secondary bile acid) and gut inflammation27. 
Similarly, leptin expression, secreted from the adipose tissue, is associated with obesity and obesity-associated 
mucosal inflammation28, 29. Therefore, in the light of our data from HFD-mice, we determined potential role/s of 
the gastrointestinal versus systemic secretomes in observed claudin switching and tight junction restructuring in 
obese mice. After optimizing the time (of treatment) and concentration of DCA that did not affect cell viability 
in polarized caco-2 cells (data not included), effects of DCA-treatment upon tight junction restructuring and 
function was determined. TER in cells cultured in the presence of DCA (20 µM) in culture medium decreased 
significantly (p < 0.05) (Fig. 5(a)). The DCA-treated cells also demonstrated a gradual increase in the apico-basal 
permeability, which became significantly higher at 8- and 24-hours post treatment data points (p < 0.001 versus 
control cells) (Fig. 5(b)). Further determinations using immunoblot analysis revealed a significant upregulation 
in claudin-2 expression (p < 0.001), as seen in obese mice gut epithelium while claudin-3 decreased markedly 
in DCA treated cells (p < 0.001) compared to the vehicle-treated cells (Fig. 5(c and d)). Similarly, significant 
decreases in the expression of other TJPs, claudin-4, claudin-7 and occludin (p < 0.05 for each proteins versus 
control cells) were also observed in DCA-treated cells (Fig. 5(c and d)). However, DCA-treatment did not affect 
claudin-1, occludin, beta-catenin and E-cadherin expressions (Fig. 5(c and d)). Immunofluorescence depicted 
intense claudin-2 staining at cell-cell junction along with vesicular cytosolic staining which further increased with 
DCA treatment. Membrane localized claudin-3, claudin-4 and claudin-7 proteins in control cells were largely 
decreased but it demonstrated cytosolic presence for claudin-3 protein (Fig. 5(e)). Collectively these results sup-
ported a critical role for increased bile acid secretion in response to increased dietary fat intake and, in promoting 
gut permeability by modulating claudins expression and tight junction restructuring.
Similarly, after establishing differentiated polarized monolayer in transwell filter supports, Caco-2 cells were 
exposed to leptin (500 ng) for different time points (0, 8, and 24 hrs) to determine the effect upon TER and 
paracellular permeability. Similar to the DCA-treatment, leptin-treated cells also demonstrated a significant 
drop in TER (p < 0.05 versus control cells) but only after 24 hours’ post-treatment. The apico-basal permeability 
for FITC-Dextran dye also increased in these cells in a time dependent manner and was significantly higher 
at 8 and 24-hours post-treatment time-points (Fig. 6(a and b)). Interestingly, immunoblot demonstrated that 
leptin-induced claudin switching differs markedly compared to the DCA-induced tight junction restructur-
ing. Specifically, the leptin-treatment significantly downregulated claudin-7 expression (p < 0.05) but increased 
claudin-2 (p < 0.05), claudin-3 (p < 0.05) and claudin-4 expressions significantly (p < 0.01) (Fig. 6(c and d)). 
www.nature.com/scientificreports/
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However, similar to the DCA-treatment, leptin-treatment failed to induce significant changes in claudin-1, occlu-
din, E-cadherin or beta-catenin expressions, compared to control cells (Fig. 6(c and d)). Immunofluorescent 
analysis supported the outcome from immunblot analysis (Fig. 6(e)). Taken together, our data suggested that 
Figure 4. High fat diet induces contrasting (versus gut) changes in tight junction composition in renal 
epithelium: Immunoblot analysis of total tissue lysate prepared using the kidney from ND- and HFD-fed mice 
(N = 4). (a) Glut-2 expression in HFD and ND-fed mice, as positive control; (b) Immunoblot analysis to 
determine changes in TJPs using antigen-specific antibodies; (c) Immunoblot analysis to determine changes in 
AJPs including E-cadherin and β-catenin; (d) Quantitative analysis of immunoblot band intensity for respective 
protein; (e) Representative immunofluorescent images of specific TJPs using kidney sections from HFD- and 
ND-fed mice. Values are presented as mean ± SEM ***P ≤ 0.001; **P ≤ 0.01 and *P ≤ 0.05 compared to control 
(normal chow fed mice; ND) mice.
www.nature.com/scientificreports/
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differential tissue micro-environment, as suspected to be the case in obese versus lean individuals, can modu-
late tight junction’s claudin switching that may reflect defective barrier function and possibly altered epithelial 
homeostasis.
Figure 5. Exposure of intestinal epithelial cell (IEC) to Bile acid (DCA) modulates tight junction composition 
and barrier function similar to the HFD-induced tight junction restructuring in gut epithelium. Polarized 
monolayer of Caco-2 cells was subjected to DCA (20 µM)-treatment (in complete culture medium) for different 
time-points. (a) Effect of DCA-treatment upon TER across the cell monolayer; (b) Apico-basal paracellular 
permeability in control or DCA-treated cells as described in “materials and methods”. (c) Immunoblots analysis 
of total cell lysate from control and DCA treated cells by using antigen-specific antibodies; (d) Quantitative 
analysis of the antigen specific band intensity from immunoblot analysis; (e) Representative confocal 
immunoflurescent imaging to determine cellular localization of cell-adhesion proteins (TJPs and AJPs) in 
control and DCA-treated cells. Values are presented as mean ± SEM. ***P ≤ 0.001, **P ≤ 0.01 and *P ≤ 0.05 
compared to control.
www.nature.com/scientificreports/
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In MDCK-II cells, Deoxycholic acid (DCA) and leptin-treatment inhibits claudin-2 expres-
sion. In the light of our in vivo data that obesity resulted in significant suppression of renal claudin-2 expres-
sion, contrasting the sharp increase in the intestinal epithelium, we examined if leptin and/or DCA exposure may 
have similar effects in vitro. Polarized monolayer of MDCK-II cells, widely used renal tubular epithelial cells, was 
subjected to leptin (250 ng/ml) or DCA (20 µm)-treatment, as above. Immunoblot analysis was done using sam-
ples collected 24-hours post-treatment. As demonstrated in Supplementary Fig. 1, both, leptin or DCA-treatment 
Figure 6. Leptin induced changes in intestinal epithelial barrier function are dependent on differential 
restructuring of tight junction than DCA-treatment. Polarized monolayer of Caco-2 cells was subjected to Leptin 
(500 ng)-treatment (in complete culture medium) for different time-points. (a) Effect of leptin-treatment upon 
trans-epithelial resistance across the cell monolayer; (b) Apico-basal paracellular permeability in control or 
leptin-treated cells as described in “materials and methods”. (c) Immunoblots analysis of total cell lysate from 
control and leptin treated cells by using antigen-specific antibodies; (d) Quantitative analysis of the antigen 
specific band intensity from immunoblot analysis; (e) Representative confocal immunoflurescent imaging to 
determine cellular localization of cell-adhesion proteins (TJPs and AJPs) in control and leptin-treated cells. 
Values are presented as mean ± SEM. **P ≤ 0.01 and *P ≤ 0.05 compared to control.
www.nature.com/scientificreports/
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markedly suppressed claudin-2 expression, similar to the in vivo findings. Interestingly, expression of other clau-
din proteins remained largely unmodified in same samples (Supplementary Fig. 1). Taken together, these data 
supported tissue specific effect of obese microenvironment upon tight junction restructuring.
TNFα/NF-kB/JUN MAP Kinase signaling regulates obesity-induced increase in claudin-2 
expression in intestinal epithelium. Claudin-2 is one of the highly regulated claudin proteins and mod-
ified in response to diverse cellular signals15, 30–32. Therefore, we further examined specific signaling mechanisms 
underlying obesity-induced changes in claudin-2 expression. In particular, we examined potential role of the 
TNF-α signaling in this regulation as we found significant increase in TNF-α and claudin-2 mRNA expres-
sion in HFD-fed mice colon (Fig. 7(a)). Moreover, in Caco-2 cells subjected to TNF-α treatment (10 ng/ml), 
claudin-2 expression increased sharply (Fig. 7(b and c)). TNF-α promotes NF-kB-signaling and MAPK signal-
ing33, 34. Therefore, we examined the possibility whether Leptin and/or DCA-induced claudin-2 upregulation in 
intestinal epithelium was dependent on similar signaling mechanisms. Caco-2 cells were subjected to Leptin or 
DCA-treatments and effects on diverse signaling pathways was determined. It was interesting that the leptin or 
DCA-treatment induced NF-kB and JUN MAP-Kinase signaling in time-dependent manner though the timings 
of the peak activation differed (Fig. 7(d and e)); Supplementary Fig. 2). In same samples, ERK1/2 MAP-Kinase 
activity remained largely unmodified (Fig. 7(d and e); Supplementary Fig. 2). To further determine, causal role of 
these signaling in obesity-induced claudin-2 expression, Caco-2 cells were subjected to leptin or DCA-treatments 
with or without pharmacological inhibitors for NF-kB (Bay-11-7082; 20 µm) and JUN MAP Kinase (SP600125; 
20 µm) signaling pathways. Additional wells of these cells were subjected to TNF-α-treatment in the presence of 
same inhibitors. It was interesting that inhibiting either NF-kB or JUN MAP Kinase signaling inhibited the Leptin 
or DCA-induced claudin-2 upregulation (Fig. 7(f and g)).
Biological processes enriched in claudin interacting proteins. Considering that the obesity and 
associated inflammation is foundation for pathological susceptibility, we performed an in-silico analysis to deter-
mine potential biological networking between claudin proteins and other signaling proteins. The STRING search 
operation focused especially on claudin-2 and claudin-7 interactions resulted in over 60 proteins that interacted 
with ‘claudin-2’ and over 50 with claudin-7. Figure 8 shows a summary of PANTHER functional analysis of inter-
acting proteins enriched in different biological processes35. Claudin-2 interacting proteins revealed enrichment 
of protein functions including MAPK cascade, kinase signaling cascade, response to cytokine stimulus and cell 
surface receptor signaling pathway. These proteins interacting with claudin-2 were often over expressed or acti-
vated in colorectal cancer (Supplementary Fig. 3(a), A ∩ E) but only Smad4 was the proteins that interacted with 
claudin-7 (Supplementary Fig. 3(b), A ∩ E). Similarly, the relation between claudin2 and calcium ion transport 
function was captured by A ∩ D (Supplementary Fig. 3(a) but claudin-7 interacting proteins did not show this 
function. Additionally, the relation between claudin-7 and sodium ion transport function was captured by A ∩ C. 
Supplementary Fig. 3(b), shows two proteins Wnk1 and Wnk2 with this function.
Discussion
Obesity is a state of chronic subclinical systemic inflammation, which is postulated to predispose obese individu-
als to multiple metabolic disorders30, 36. Multiple plausible mechanisms have been proposed to explain the mech-
anistic undertakings for this causal association. However, consensus seems to exist for direct association between 
a hyper-permeable gut, characterizing obese individuals, and susceptibility to obesity-associated disorders. It is 
believed that a leaky gut helps enable the crossover of luminal microbial products, such as LPS, into the blood 
stream causing sub-optimal systemic inflammation17, 37. Also, the possibility that a leaky gut may help modulate 
gut microbiota by influencing the micro-environment cannot be ruled out. A critical role of gut microbiota in 
human health is now well recognized but the molecular undertakings of obesity-induced barrier deregulation 
remain ill understood. In the present study, using a comprehensive in vivo and in vitro analysis, we demonstrate 
organ and tissue-specific claudin switching as potential cause for obesity-associated tight junction restructuring 
and mucosal barrier deregulations. Our data that obesity-associated secrotomes induce variable changes in clau-
din expression, despite similar deregulation of intestinal epithelial cell barrier integrity, implicate greater roles of 
claudin proteins in obesity-associated pathobiology than the barrier deregulation. Overall, our findings highlight 
for the first time, in our knowledge, clinical significance of claudin expression, especially claudin-2, and tight 
junction restructuring in dealing with the obesity-associated epidemic.
These studies were performed using the validated approach of inducing obesity in mice by feeding high-calorie 
diet, the key detrimental factor in promoting obesity. Our findings that in HFD-mice, the trans-epithelial resist-
ance was markedly decreased while crossover of luminally applied FITC-Dextran through rectum into the blood 
plasma was significantly higher, compared to the ND-mice, clearly supports deregulated tight junction properties 
and mucosal barrier properties. Our in vitro studies where polarized monolayer of cultured IEC was exposed to 
leptin, entrusted to regulate appetite and body weight and deregulated in obese individuals, clearly recapitulated 
the findings in vivo. Similar barrier deregulation in cultured IECs in response to DCA-exposure however accom-
panied by differential modulation of claudin protein expression implicates complex interaction between the tissue 
microenvironment, tight junction restructuring and barrier deregulation. As described, bile acid secretion is 
upregulated upon high-fat dietary intake38. Similar findings by other laboratories that obesity, leptin-treatment 
or DCA-treatment increases permeability across intestinal epithelium support our findings38.
The claudin family of transmembrane proteins is integral constituent of the tight junction and is expressed in 
tissue and in cell-specific manners39. Moreover, changes in claudin proteins, especially upregulation of claudin-2 
protein, in association with pathological leakiness has been widely described13, 15. We have recently demonstrated 
that claudin-2 overexpression in intestinal epithelium in mice suffice to induce hyper-permeability13. However, in 
current study, obese mice gut epithelium presented diverse changes in tight- and adherent junction constituent 
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proteins between small and large intestine. In this regard, studies have now highlighted discrete role of specific 
claudin proteins in regulating paracellular ion transport40, 41. The pathobiological significance of this function 
Figure 7. TNFα/NF-kB/JUN MAP-Kinase Signaling regulates obesity-induced increase in claudin-2 
expression in intestinal epithelium. (a) qRT-PCR using total RNA isolated from control or HFD-fed mice 
colon; (b) Effect of TNF-α treatment upon claudin-2 expression in Caco-2 cells; (c) Quantitative analysis of the 
band intensity from immunoblot analysis; (d and e) Effect of leptin or DCA-treatments upon cellular signaling 
mechanisms and quantitative analysis of the antigen specific band intensity from immunoblot analysis; (f and 
g) Effect of inhibiting NF-kB or JUN MAP Kinase signaling using pathways specific inhibitors upon leptin or 
TNF-α induced increases in claudin-2 expressionand quantitative analysis of the antigen specific band intensity 
from immunoblot analysis; Values are presented as mean ± SEM. ***P ≤ 0.001, **P ≤ 0.01 and *P ≤ 0.05 
compared to control.
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of claudin proteins in metabolic regulation is highlighted by recent findings that genetic inhibition of claudin-2 
and -15 proteins, responsible for paracellular Na+ transport, resulted in malnourishment and premature death42. 
Here, inefficient functioning of the Na+-dependent transporters responsible for nutrient absorption from gut 
was found to be the underlying cause42. Notably, obese individuals have problem with effective digestion and 
nutrient absorption43, 44. Also, claudin-2 null mice demonstrate susceptibility to gallbladder stone45. In both cases, 
inefficient paracellular transport of Na+ due to the loss of claudin-2 and/or -15 appeared central to the patho-
logical problems42. In our studies, we have found profound but tissue-specific alterations in claudin-2 and 15 
proteins. Additionally, the in-silico analysis highlighted the key association between claudin-2 expression and 
Na+-homeostasis. A key role of deregulated Na+-homeostasis in obesity associated co-morbidities including 
hypertension is well documented46. Uniquely, claudin-2 protein also helps transport calcium and is a direct target 
for Vitamin-D receptor47. Significance of calcium homeostasis in health and disease including gastro-intestinal 
diseases is well established48. Overall, based on our data it is tempting to speculate that differential ion homeosta-
sis, due to tissue specific claudin switching, may help modulate gut microenvironment and associated microbiota 
to promote barrier deregulation and disease susceptibility.
Here, it is notable that the changes in renal claudin-2 expression in obese mice contrasted the significant 
upregulation in gut epithelium in vivo and in vitro. Importantly, claudin-2 protein in the renal epithelium is 
expressed predominantly in the proximal tubular epithelium, the principal absorptive site for ions and solutes, 
including sodium and water in the kidney11. Accordingly, claudin-2 null mice demonstrate defective sodium 
handling and absorption49. Thus, the possibility that the reduced renal claudin-2 expression may impact blood 
Na+ -levels by waning proximal tubular reabsorption to aid to obesity-associated co-morbidities including hyper-
tension cannot be ruled out. Additionally, the lack of renal claudin-2 expression was recently demonstrated to 
promote hypoxic environment and increased susceptibility to ischemic injury26. Similarly, renal claudin-7 defi-
ciency is associated with renal salt wasting and chronic dehydration50. Interestingly, claudin-4 expressed predom-
inantly in collecting ducts and serving as chloride permeability determinants was markedly upregulated in HFD 
diet mice kidney51. The increase in claudin-4 was however compensated by suppressed expression of the sister 
claudin protein, claudin-3, which share structural and functional properties with claudin-4. Taken together, renal 
claudin switch in HFD-mice (versus ND-mice) suggested profound alterations in renal ion homeostasis in HFD- 
versus ND-mice. However, elaborate studies with specific modulation of candidate proteins would be required for 
clear understanding of the role these proteins may play in regulating obesity associated metabolic disorder and 
co-morbidities.
Yet another consideration for the differential and tissue-specific changes in claudin expression could be their 
non tight-junctional functions. In this regard, loss of intestinal claudin-7 expression resulted in epithelial cell 
sloughing and spontaneous inflammation52. We have previously demonstrated a sharp decrease in claudin-7 
expression in transformed intestinal epithelium and its causal association with carcinogenesis53. Similarly, a 
decrease in intestinal claudin-3 expression, as seen in our studies, has been associated with immature gut and 
barrier deregulations, and dedifferentiated gut epithelium54, 55. Claudin-1 expression is similarly associated with 
dedifferentiated gut epithelium depending upon its expression levels and cellular distribution22, 56, 57. On the other 
hand, decreased claudin-15 expression and an increase in claudin-2 expression in mice induce proliferation13, 58. 
Figure 8. In silico analysis of claudin-2 and claudin-7 interaction in biological processes. Functional 
enrichment of proteins known to interact with claudin-2 and claudin-7: Many of the proteins that interact with 
claudin-2 encompass many biological processes including MAPK cascade and cell surface receptor signaling 
pathways, the proteins interacting with claudin-7 were enriched in fewer processes and were primarily involved 
in epithelial development.
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Thus, taking into consideration the diverse however robust changes in specific claudin proteins, it is tempting to 
speculate that observed changes may reflect altered differentiated status of respective epithelia in obese mice. Of 
note, obese individuals are more susceptible to oncological transformations and growth including colon and renal 
cancers than healthy individuals59, 60.
An important question however remains regarding potential regulators of the tight junction remodeling in the 
gut and other organs in response to HFD-mice and obesity. We believe it is not the HFD that is responsible for the 
remodeling of the tight junction and barrier composition but it is the bodily responses to high caloric food intake. 
In this regard, excessive and prolong dietary fat increases levels of bile acids in intestinal lumen and leptin levels 
in blood circulation61–64. We hypothesize that the bile acids and leptin are the potential mediators of the observed 
claudin switch and barrier remodeling, possibly by modulating the local and/or systemic immune homeostasis. 
Our data from in vitro modelling supports such a postulation and implicates the role of TNF-α/NF-kB/JUN 
MAP-Kinase signaling in this regulation. A causal association between inflammatory signaling and barrier dereg-
ulation has previously been demonstrated and the role of the TNF-α and NF-kB signaling in regulating claudin-2 
expression has been reported30, 34, 65. Our findings corroborate well with previous in-vitro reports showing that 
bile acids and fat emulsion treatment modulate barrier composition and function in IECs38. On the other hand, 
leptin secreted mostly from adipose tissue, regulate the energy homeostasis while leptin from gastric secretion 
inhibits intestinal sugar absorption by modulating sodium-glucose transporter 1 activity while luminal leptin 
enhances intestinal absorption of dietary proteins by stimulating peptide transport activity. Here, we demon-
strated that apical leptin treatment significantly modulates tight junction composition by increasing claudin-2 
and -3 expressions and decreasing claudin-7 expression, which might explain the decreased TER and increased 
paracellular permeability in polarized caco-2 cells. Our data further signifies the tissue-specificity of these effects 
as similar treatments of MDCK-II cells affect claudin expression differentially and inhibits claudin-2 expression.
Taken together, we here present, for the first time, a comprehensive analysis of the effects of high calorie and 
fat enriched diet upon gut permeability and tight junction restructuring. Our novel findings describe diverse and 
tissue specific changes in tight junction and adherent junction proteins in HFD-induced obesity versus ND-mice 
that is supportive of significant changes in barrier properties, ion homeostasis and epithelial homeostasis, which 
together may predispose obese individuals to differing pathological conditions.
Methods
Materials. High fat diet (HFD; 60% of total calories from fat) was obtained from the Bio Serv, New 
Jersey. The antibodies against claudin proteins Claudin-1 (Cat#717800), Claudin-2 (Cat#325600), Claudin-3 
(Cat#341700), Claudin-4 (Cat#364800), Claudin-7 (Cat#374800) and Claudin-15 (Cat#389200) were purchased 
from Invitrogen Inc. (Carlsbad, CA), against E-cadherin (Cat#610181) and β-catenin (Cat#610153) from BD 
Biosciences (Franklin Lakes, NJ). The anti-β-actin antibody (Cat#A5441), deoxycolic acid (Cat#D2510) and lep-
tin (Cat#L4146) were purchased from Sigma-Aldrich (St. Louis, MO). The human TNF-α was purchased from 
R&D Systems Inc. (Minneapolis, MN) while BAY-11-7082 (NFkB inhibitor) and SP600125 (JNK inhibitor) were 
obtained from Sigma Aldrich (St Louis, MO, USA).
The intestinal epithelial cells, Caco-2, were obtained from ATCC and cultured in DMEM-high glucose 
medium containing 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. All cell culture reagents were 
from Invitrogen (San Francisco, CA, USA).
High fat diet induced Obesity in mice. All experimental procedures were carried out in accordance with 
the Guidelines for the Care and Use of Laboratory Animals. All animal experiments in this study followed proto-
cols approved by the Institutional Animal Care and Use Committee (IACUC) of University of Nebraska Medical 
Center, Omaha, Nebraska. C57BL/6 mice were purchased from the Jackson laboratory (Bar Harbor, ME) and 
then bred in our animal facility under specific pathogen–free conditions. Adult mice (8–10 weeks old) were used 
in this study. Mice had free access to normal chow (4% fat; control mice) or High fat chow (60% fat; experimental 
animals) except when fasted prior to the oral glucose tolerance test (OGTT). Food intake and body weight were 
monitored weekly and metabolic studies were performed as indicated below. Mice were sacrificed at 20 weeks’ 
post feeding of manipulated diet and small intestine, colon, adipose tissue, heart, liver, and kidney were harvested 
for further evaluations.
Oral glucose tolerance test (OGTT). The OGTT test was performed at the Mouse Metabolic Core at 
Vanderbilt University Medical Center (VUMC), Nashville, TN. In brief, fasted mice were weighed and fasting 
blood glucose level was measured immediately prior to the OGTT. A 50% glucose solution was given orally 
(2.5 g/kg) and blood glucose was measured at 15, 30, 60, and 120 min after glucose administration as described 
previously38.
Determination of gut permeability. In vivo intestinal permeability assay to evaluate barrier deregula-
tion was done using FITC-labeled dextran, MW 4000 (FD4 Sigma-Aldrich) as previously described13. Briefly, 
mice were orally administrated (gavage) FITC dextran-dextran with feeding needle (60 mg/100 g body weight of 
FITC-labeled dextran). Serum was collected retro-orbitally four hours later and fluorescence intensity was deter-
mined by using microplate fluorescence reader (excitation, 485 nm; emission, 528 nm; Bio-Tek).
Western blot analysis. Immunoblot analysis was performed as previously described57. Signal was detected 
using an enhanced chemiluminescence detection kit (Amersham Biosciences). Equal protein loading was deter-
mined by re-probing with anti-β actin antibody after stripping the respective membrane.
Trans-epithelial resistance and apico-basal permeability. For measurement of the trans-epithelial 
resistance (TER), caco-2 cell monolayers were grown on transwell filters (0.4 µm) and TER across the monolayer 
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was assessed using an electrical resistance meter (Millipore, Bradford, MA). Cells cultured for at least three days, 
prior to experimental manipulations, to ensure polarized monolayer, were used. Measurements are presented as 
Ω⋅cm2 and expressed as percentage change compared to the baseline value. The paracellular flux for non-charged 
molecules was determined as described previously using FITC- dextran (4 kDa, Sigma-Aldrich Inc.)15. Data are 
presented as the total amount of FITC-dextran collected in the bottom chamber of transwell at indicated time 
points.
Colonic trans-epithelial resistance measurement using the Ussing chamber system. Colonic 
epithelial sheets form HFD and ND-fed mice were harvested immediately after sacrificing and mounted in the 
dual channel Ussing Chamber system (Physiologic Instrument, San Diego, CA). The trans-epithelial resistance 
and conductance across the epithelium sheets were measured as previously described13.
Immunohistochemistry. Immunofluorescent staining was done as described previously56. Briefly, 
cells were fixed with 95% ethanol for 20 min at 4 °C, then permeabilized with 0.2% Triton X-100 for 15 min. 
Immunofluorescence staining using tissues sections was performed using Tris-EDTA pH 9.0 buffer for antigen 
unmasking in relocking chamber (Biocare Medical, CA). Imaging for the immuno-labeled cells was performed 
using confocal microscope at the University of Nebraska Medical Center (UNMC) Imaging Core. All the images 
included in this manuscript were captured under identical microscope setting (for each antigen) and processed 
using the Adobe Photoshop (Adobe System, San Jose, CA) in identical manner.
In silico analysis of tight junction proteins interaction. The complete mouse PPI network was 
obtained from STRING database and an induced sub-network was created using a gene list, which was obtained 
from multiple sources including STRING, GO and KEGG. Protein-protein interaction information was obtained 
for both claudin-2 and -7 protein, using STRING database66. Whereas all the genes annotated to have calcium/
sodium ion transport functions were obtained from GO, the genes annotated with tight junction and colorectal 
cancer pathways were obtained from KEGG database. The proteins interacting with claudin-2 (or claudin-7) 
involved in multiple functions of interest were identified and labeled accordingly and visualized using Cytoscape 
(Supplementary Fig. 3a and b).
Statistical analysis. Statistical analysis was done using Student’s t or one-way ANOVA in GraphPad Prism 
6.0 (GraphPad Software, Inc.). A p-value < 0.05 was defined as statistically significant. All data presented are 
representative of at least three repeat experiments and presented as mean ± SEM.
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